Industry
Medical - Instruments & Supplies
Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Insights
July 27, 2023 | 1:06 pm
Portfolio Pulse from Happy Mohamed
July 27, 2023 | 12:46 pm
Portfolio Pulse from Lisa Levin
July 10, 2023 | 12:11 pm
Portfolio Pulse from richadhand@benzinga.com
July 03, 2023 | 10:03 am
Portfolio Pulse from Benzinga Insights
June 27, 2023 | 1:12 pm
Portfolio Pulse from Benzinga Insights
June 26, 2023 | 5:37 pm
Portfolio Pulse from Lisa Levin
June 26, 2023 | 4:31 pm
Portfolio Pulse from Adam Eckert
June 26, 2023 | 1:30 pm
Portfolio Pulse from Benzinga Insights
June 26, 2023 | 1:12 pm
Portfolio Pulse from Benzinga Newsdesk
June 26, 2023 | 12:43 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.